AI Proteins
Andover, US · Founded 2021 · Delaware corporation · 40 employees on LinkedIn · 3 known investors
AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.
Founders & leadership
AI Proteins was founded in 2021 by Chris Bahl.
CB
Chris BahlinFounder
DV
Dominique VerhelleNamed on SEC filing
BM
Bill McKeeNamed on SEC filing
JN
Julia NovinaNamed on SEC filing
MA
GM
Geoff MeyersonNamed on SEC filing
EP
Elena ProkupetsNamed on SEC filing
CN
Carl NovinaNamed on SEC filing
DD
Drew DennisonNamed on SEC filing
NB
Namandje BumpusNamed on SEC filing
MS
Malcolm SalterNamed on SEC filing
Board
AB
Investors · 3
Funding
SEC filings, press & company announcements$66.1M disclosed across 4 rounds · 2022–2025
- $41.5MSeries ANov 2025 · 3 sourcesSource ↗
▶$5MraisedApr 2024 · 8 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bobby SandageDirector
- Julia A. NovinaExecutive Officer
- Chris BahlExecutive Officer, Director
- Bruce EvansDirector
- Drew DennisonDirector
- Wendy DwyerExecutive Officer
- Todd KaloudisDirector
- Noah BeermanExecutive Officer, Director
- Malcolm SalterDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$8.3MraisedAug 2023 · 7 investors · BiotechnologyRule 506(b)
▶$8.3MraisedAug 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noah BeermanExecutive Officer
- Mark AllesDirector
- Malcolm SalterDirector
- Todd KaloudisDirector
- Bobby SandageDirector
- Chris BahlExecutive Officer, Director
- Julia A. NovinaExecutive Officer
- Drew DennisonDirector
- Bruce EvansDirector
- Offering amount
- $10M
- Amount sold
- $8.3M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$11.3MraisedJan 2022 · 38 investors · BiotechnologyRule 506(b)
▶$11.3MraisedJan 2022 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dominique VerhelleDirector
- Bill McKeeDirector
- Julia NovinaExecutive Officer
- Marc A. CohenExecutive Officer, Director
- Geoff MeyersonDirector
- Elena ProkupetsDirector
- Carl NovinaDirector
- Drew DennisonDirector
- Namandje BumpusDirector
- Arthur BeckerDirector
- Chris BahlExecutive Officer, Director
- Malcolm SalterDirector
- Offering amount
- $18.2M
- Amount sold
- $11.3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through AI Proteins went on to found or lead other companies.
In the news
Frequently asked questions
- What does AI Proteins do?
- AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.
- Who founded AI Proteins?
- AI Proteins was founded by Chris Bahl in 2021.
- Who are AI Proteins's investors?
- AI Proteins's investors include Mission Biocapital, Tachyon Ventures, Cobro Ventures.
- How much funding has AI Proteins raised?
- AI Proteins has disclosed $66.1M raised across 4 rounds.
- Where is AI Proteins headquartered?
- AI Proteins is headquartered in Andover, US.